Relapsing Remitting Multiple Sclerosis

Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

MS Relapses During COVID-19 Pandemic

Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis

Functional Outcomes From Diets in Multiple Sclerosis

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis

Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis

Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

Cladribine Tablets as an Exit Therapy Strategy

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Administration of Fingolimod in Greek Patients With Multiple Sclerosis.